These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11514369)

  • 41. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
    Tsai HC; Shi MH; Lee SS; Wann SR; Tai MH; Chen YS
    Clin Microbiol Infect; 2011 May; 17(5):780-4. PubMed ID: 21521415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
    Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
    Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Age-related dynamics of the contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) in blood plasma of residents of the European part of the Arctic zone of the Russian Federation.].
    Kim LB; Russkih GS; Putyatina AN; Tsypysheva OB
    Adv Gerontol; 2018; 31(2):223-230. PubMed ID: 30080329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis.
    Matsuyama T
    Pediatr Int; 1999 Jun; 41(3):239-45. PubMed ID: 10365570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    Duits FH; Hernandez-Guillamon M; Montaner J; Goos JD; Montañola A; Wattjes MP; Barkhof F; Scheltens P; Teunissen CE; van der Flier WM
    J Alzheimers Dis; 2015; 48(3):711-20. PubMed ID: 26402072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of choline treatment in concentrations of serum matrix metalloproteinases (MMPs), MMP tissue inhibitors (TIMPs) and immunoglobulins in an experimental model of canine sepsis.
    Kocaturk M; Eralp-Inan O; Tvarijonaviciute A; Cansev M; Ozyigit MO; Ceron JJ; Yilmaz Z; Kahraman MM
    Vet Immunol Immunopathol; 2016 Nov; 180():9-14. PubMed ID: 27692098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients.
    Voutilainen SH; Kosola SK; Tervahartiala TI; Sorsa TA; Jalanko HJ; Pakarinen MP
    Transpl Int; 2017 Feb; 30(2):124-133. PubMed ID: 27774663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease.
    Heider P; Pelisek J; Poppert H; Eckstein HH
    Vasc Endovascular Surg; 2009 Dec; 43(6):551-60. PubMed ID: 19640916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases in isolated hypercholesterolemia.
    Malik J; Stulc T; Ceska R
    Int Angiol; 2005 Sep; 24(3):300-3. PubMed ID: 16158043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.
    Alvarez-Sabín J; Delgado P; Abilleira S; Molina CA; Arenillas J; Ribó M; Santamarina E; Quintana M; Monasterio J; Montaner J
    Stroke; 2004 Jun; 35(6):1316-22. PubMed ID: 15087562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
    Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
    Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with incisional hernia.
    Henriksen NA; Sørensen LT; Jorgensen LN; Agren MS
    Wound Repair Regen; 2013; 21(5):661-6. PubMed ID: 23927724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease.
    Korematsu S; Ohta Y; Tamai N; Takeguchi M; Goto C; Miyahara H; Kawano T; Izumi T
    Pediatr Infect Dis J; 2012 Sep; 31(9):973-4. PubMed ID: 22895216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum MMPs and TIMPs: may be predictors of breast carcinogenesis?
    Zagouri F; Sergentanis TN; Kalogera E; Provatopoulou X; Chrysikos D; Zografos E; Bletsa G; Flessas I; Papadimitriou CA; Zografos GC; Gounaris A
    Clin Chim Acta; 2011 Mar; 412(7-8):537-40. PubMed ID: 21130755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Bradham WS; Gunasinghe H; Holder JR; Multani M; Killip D; Anderson M; Meyer D; Spencer WH; Torre-Amione G; Spinale FG
    J Am Coll Cardiol; 2002 Dec; 40(12):2165-73. PubMed ID: 12505230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal circulating levels of matrix metalloproteinases and their inhibitors in diabetes mellitus.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Ftouhi B; Feki M; Slimane H; Kaabachi N
    Clin Lab; 2012; 58(7-8):779-85. PubMed ID: 22997979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
    Schäfer M; Ivy DD; Nguyen K; Boncella K; Frank BS; Morgan GJ; Miller-Reed K; Truong U; Colvin K; Yeager ME
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H242-H252. PubMed ID: 34085841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.